MAF BZIP Transcription Factor A (MAFA)

MAF BZIP Transcription Factor A (MAFA) is a critical transcription factor that serves as a master regulator of pancreatic beta-cell function and insulin gene expression [1][3]. It specifically binds to the RIPE3b/C1 element within the insulin promoter, acting as a potent transactivator that responds to glucose fluctuations to maintain metabolic homeostasis [3]. MAFA is essential for the functional maturation of beta cells; its expression is often lost or significantly reduced in chronic hyperglycemia, contributing to the beta-cell failure observed in type 2 diabetes [5]. Beyond insulin, MAFA regulates a network of genes vital for glucose sensing and secretion, such as GLUT2 and Prohormone Convertase 1/3 [1]. While the genomic DNA regulatory elements bound by MAFA are the sites of its activity, the MAFA protein itself is the primary therapeutic target of interest for restoring beta-cell identity [2]. Mutations in MAFA have been clinically linked to familial insulinomatosis and various forms of diabetes, highlighting its dual role in regulating both cellular proliferation and glucose metabolism [4].

Other names

V-maf musculoaponeurotic fibrosarcoma oncogene homolog ARIPE3b1Transcription factor MaFAhMAFAPancreatic beta-cell-specific transcription factor

MAFA binds to the conserved C1 element (also known as RIPE3b) within the insulin gene promoter to activate transcription in a glucose-dependent manner. It acts as a terminal differentiation marker for beta cells, coordinating the expression of genes required for mature beta-cell function, including SLC2A2 (GLUT2), PDX1, and GCK (Glucokinase).